WallStreetZenWallStreetZen

NASDAQ: GRFS
Grifols Sa Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Grifols Sa earnings were $467.4M for the trailing 12 months ending Dec 31, 2025, with 189.2% growth year over year. For the last reported fiscal year 2025 ending Dec 31, 2025, GRFS reported annual earnings of $472.9M, with 189.2% growth.

GRFS past earnings growth

How has GRFS's earnings growth performed historically?

Company
189.17%
Industry
41.72%
Market
91.9%
GRFS's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
GRFS's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
GRFS's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

GRFS earnings history

Current Revenue
$8.9B
Current Earnings
$472.9M
Current Profit Margin
5.3%
GRFS's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

GRFS Return on Equity

Current Company
7.2%
Current Industry
8.1%
Current Market
28.9%
GRFS's Return on Equity (7.2%)... subscribe to Premium to read more.
High Return on Equity Performance

GRFS Return on Assets

Current Company
2%
Current Industry
12.6%
GRFS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when GRFS announces earnings.

GRFS Return on Capital Employed

Current Company
6.45%
Current Industry
21.4%
GRFS has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

GRFS vs General Drug Manufacturer Stocks

TickerEBITDAEarningsY/Y EarningsEPS
GRFS$1.85B$467.44M-8.77%$0.69
OGN$1.39B$246.00M-33.69%$0.94
AMRN-$27.75M-$33.61MN/A-$1.60
SCLX-$359.15M-$419.68MN/A-$40.47
MIRA-$9.81M-$31.37MN/A-$1.27
View Top General Drug Manufacturer Stocks

Grifols Sa Earnings Reports & History FAQ

What was GRFS's earnings growth in the past year?

As of Grifols Sa's earnings date in Invalid Date, Grifols Sa's earnings has grown 189.17% year over year. This is 147.45 percentage points higher than the US Drug Manufacturers - General industry earnings growth rate of 41.72%. GRFS earnings in the past year totalled $467.44 million.

If you're new to stock investing, here's how to buy Grifols Sa stock.

Is Grifols Sa profitable or losing money?

As of the last Grifols Sa earnings report, Grifols Sa is currently profitable. Grifols Sa's net profit (also called net income) for the twelve months ending Dec 31, 2025 was $472.94 million, a 189.19% increase year over year.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.